BioLife Solutions, Inc. (BLFS) has a MoatMap StockRank of 50/100 based on Quality (53/100), Value (18/100), and Momentum (66/100) factor scores. The current signal is HOLD. BioLife Solutions is a key supplier of biopreservation media and tools for cell and gene therapies. It acts as a pick-and-shovel play for advanced therapeutics, but its financial performance remains volatile and highly dependent on biotech funding cycles.
BioLife Solutions, Inc. provides proprietary biopreservation media, thawing devices, and cloud-based cold chain management solutions for the cell and gene therapy markets. As a market leader, its proprietary media and thawing technologies are becoming industry standards for cell and gene therapy clinical trials and commercialization, creating significant customer stickiness. The company serves nearly all major cell and gene therapy clinical trials globally.
| Price | $27.55 |
| Market Cap | $1.2B |
| P/E (Forward) | 93.41 |
| Price/Book | 3.55 |
| Return on Equity | -3.1% |
| Return on Invested Capital | -4.3% |
| Debt/Equity | 3.99 |
| Gross Margin | 63.8% |
| Operating Margin | 0.1% |
| Revenue Growth | 24.7% |
| Free Cash Flow | $6M |
BioLife Solutions, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).